Lymphatic endothelial regulation, lymphoedema, and lymph node metastasis

Seminars in Cell and Developmental Biology

Volumn 13, Issue 1, 2002, Pages 9-18

  Karkkainen, Marika J ^a   Alitalo, Kari ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Lymphangiogenesis; Lymphatic vasculature; Metastasis; VEGF C; VEGFR 3

Indexed keywords

ALPHA9BETA1 INTEGRIN; ANGIOGENIC FACTOR INHIBITOR; ANGIOPOIETIN 2; CELL SURFACE PROTEIN; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR D6; HYALURONIC ACID DERIVATIVE; INTEGRIN; LYMPHATIC VESSEL ENDOTHELIAL HYALURONAN RECEPTOR 1; NEUROPILIN 2; PODOPLANIN; PROTEIN INHIBITOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXC2; TRANSCRIPTION FACTOR NET; TRANSCRIPTION FACTOR PROX1; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR 3;

ARTICLE; CANCER INHIBITION; CARBOXY TERMINAL SEQUENCE; CELL GROWTH; CELL MIGRATION; CELL SURVIVAL; CELL TYPE; CHROMOSOME XP; CHYLOTHORAX; CLINICAL FEATURE; DRUG EFFECT; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; GENE INSERTION; GENE LOCUS; GENE MAPPING; GENE THERAPY; GENOTYPE; HUMAN; LYMPH NODE METASTASIS; LYMPH VESSEL ENDOTHELIUM; LYMPHATIC SYSTEM; LYMPHEDEMA; LYMPHOEDEMA DISTICHIASIS; MILROY DISEASE; MUTATION; NERVE CELL DIFFERENTIATION; NONHUMAN; PHENOTYPE; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN ISOLATION; REGULATORY MECHANISM; TURNER SYNDROME;

INSERTION SEQUENCES;

EID: 0036443964     PISSN: 10849521     EISSN: None     Source Type: Journal    
DOI: 10.1006/scdb.2001.0286     Document Type: Article

References (100)

1. Sabin FR (1902) On the origin of the lymphatic system from the veins and the development of the lymph hearts and thoracic duct in the pig. Am J Anat 1:367-391
2. Huntington GS, McClure CFW (1908) The anatomy and development of the jugular lymph sac in the domestic cat (Felis domestica). Anat Rec 2:1-19
3. Kampmeier OF (1912) The value of the injection method in the study of lymphatic development. Anat Rec 6:223-232
4. van der Jagt ER (1932) The origin and development of the anterior lymph sacs in the sea turtle (Thalassochelys caretta). Q J Microbiol Sci 75:151-165
5. Kaipainen A, Korhonen J, Mustonen T, van Hinsbergh VWM, Fang G-H, Dumont D, Breitman M, Alitalo K (1995) Expression of the fms-like tyrosine kinase FLT4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 92:3566-3570
6. Dumont DJ, Jussila L, Taipale J, Lymboussaki A, Mustonen T, Pajusola K, Breitman M, Alitalo K (1998) Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science 282:946-949
7. Wigle JT, Oliver G (1999) Prox1 function is required for the development of the murine lymphatic system. Cell 98:769-778
8. Schneider M, Othman-Hassan K, Christ B, Wilting J (1999) Lymphangioblasts in the avian wing bud. Dev Dyn 216:311-319
9. Wilting J, Schneider M, Papoutsi M, Alitalo K, Christ B (2000) An avian model for studies of embryonic lymphangiogenesis. Lymphology 33:81-94
10. Wilting J, Papoutsi M, Schneider M, Christ B (2000) The lymphatic endothelium of the avian wing is of semitic origin. Dev Dyn 217:271-278
11. Rescigno M, Borrow P (2001) The host-pathogen interaction: New themes from dendritic cell biology. Cell 106:267-270
12. Galland F, Karamysheva A, Pebusque M-J, Borg J-P, Rottapel R, Dubreuil P, Rosnet O, Birnbaum D (1993) The FLT4 gene encodes a transmembrane tyrosine kinase related to the vascular endothelial growth factor receptor. Oncogene 8:1233-1240
13. Pajusola K, Aprelikova O, Korhonen J, Kaipainen A, Pertovaara L, Alitalo R, Alitalo K (1992) FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines. Cancer Res 52:5738-5743
14. Partanen TA, Arola J, Saaristo A, Jussila L, Ora A, Miettinen M, Stacker SA, Achen MG, Alitalo K (2000) VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues. FASEB J 14:2087-2096
15. Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N, Alitalo K (1996) A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 15:290-298
16. Lee J, Gray A, Yuan J, Luoh S-M, Avraham H, Wood WI (1996) Vascular endothelial growth factor-related protein: A ligand and specific activator of the tyrosine kinase receptor Flt4. Proc Natl Acad Sci USA 93:1988-1992
17. Orlandini M, Marconcini L, Ferruzzi R, Oliviero S (1996) Identification of a c-fos-induced gene that is related to the platelet-derived growth factor/vascular endothelial growth factor family. Proc Natl Acad Sci USA 93:11675-11680
18. Yamada Y, Nezu J, Shimane M, Hirata Y (1997) Molecular cloning of a novel vascular endothelial growth factor VEGF-D. Genomics 42:483-488
19. Achen MG, Jeltsch M, Kukk E, Makinen T, Vitali A, Wilks AF, Alitalo K, Stacker SA (1998) Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 4 (Flt4). Proc Natl Acad Sci USA 95:548-553
20. Joukov V, Sorsa T, Kumar V, Jeltsch M, Claesson-Welsh L, Cao Y, Saksela O, Kalkkinen N, Alitalo K (1997) Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J 16:3898-3911
21. Stacker SA et al. (1999) Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers. J Biol Chem 274:32127-32136
22. Cao Y, Linden P, Farnebo J, Cao R, Eriksson A, Kumar V, Qi J-H, Claesson-Welsh L, Alitalo K (1998) Vascular endothelial growth factor C induces angiogenesis in vivo. Proc Natl Acad Sci USA 95:14389-14394
23. Marconcini L, Marchio S, Morbidelli L, Cartocci E, Albini A, Ziche M, Bussolino F, Oliviero S (1999) c-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro. Proc Natl Acad Sci USA 96:9671-9676
24. Joukov V, Kumar V, Sorsa T, Arighi E, Weich H, Saksela O, Alitalo K (1998) A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation, and vascular permeability activities. J Biol Chem 273:6599-6602
25. Baldwin ME, Catimel B, Nice EC, Roufail S, Hall NE, Stenvers KL, Karkkainen MJ, Alitalo K, Stacker SA, Achen MG (2001) The specificity of receptor binding by vascular endothelial growth factor-D is different in mouse and man. J Biol Chem 276:19166-19171
26. Oh S-J, Jeltsch MM, Birkenhager R, McCarthy JE, Weich HA, Christ B, Alitalo K, Wilting J (1997) VEGF and VEGF-C: Specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev Biol 188:96-109
27. Jeltsch M, Kaipainen A, Joukov V, Meng X, Lakso M, Rauvala H, Swartz M, Fukumura D, Jain RK, Alitalo K (1997) Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276:1423-1425
28. Mandriota SJ et al. (2001) Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J 20:672-682
29. Veikkola J et al. (2001) Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice. EMBO J 6:1223-1231
30. Mäkinen T et al. (2001) Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nat Med 7:199-205
31. Wigle JT, Chowdhury K, Gruss P, Oliver G (1999) Prox1 function is crucial for mouse lens-fibre elongation. Nat Genet 21:318-322
32. Sosa-Pineda B, Wigle JT, Oliver G (2000) Hepatocyte migration during liver development requires Prox1. Nat Genet 25:254-255
33. Breiteneder-Geleff S, Matsui K, Soleiman A, Meraner P, Poczewski H, Kalt R, Schaffner G, Kerjaschki D (1997) Podoplanin, novel 43-kd membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis. Am J Pathol 151:1141-1152
34. Matsui K, Breitender-Geleff S, Soleiman A, Kowalski H, Kerjaschki D (1999) Podoplanin, a novel 43-kDA membrane protein, controls the shape of podocytes. Nephrol Dial Transplant 14:9-11
35. Breiteneder-Geleff S et al. (1999) Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: Podoplanin as a specific marker for lymphatic endothelium. Am J Pathol 154:385-394
36. Mäkinen T et al. (2001) Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C receptor VEGFR-3. EMBO J 20:4762-4773
37. Kriehuber E, Breiteneder-Geleff S, Groeger M, Soleiman A, Schoppmann SF, Stingl G, Kerjaschki D, Maurer D (2001) Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages. J Exp Med 194
38. Weninger W et al. (1999) Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells. Lab Invest 79:243-251
39. Banerji S, Ni J, Wang S-X, Clasper S, Su J, Tammi R, Jones M, Jackson DG (1999) LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 144:789-801
40. Prevo R, Banerji S, Ferguson DJP, Clasper S, Jackson DG (2001) Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium. J Biol Chem 276:19420-19430
41. Protin U, Schweighoffer T, Jochum W, Hilberg F (1999) CD44-deficient mice develop normally with changes in sub-populations and recirculation of lymphocyte subsets. J Immunol 163:4917-4923
42. DeGrendele HC, Estess P, Siegelman MH (1997) Requirement for CD44 in activated T cell extravasation into an inflammatory site. Science 278:672-675
43. Auvinen P, Tammi R, Parkkinen J, Tammi M, Agren U, Johansson R, Hirvikoski P, Eskelinen M, Kosma VM (2000) Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival. Am J Pathol 156:529-536
44. Huang XZ, Wu JF, Ferrando R, Lee JH, Wang YL, Farese RV Jr, Sheppard D (2000) Fatal bilateral chylothorax in mice lacking the integrin α9β1. Mol Cell Biol 20:5208-5215
45. Wang JF, Zhang X-F, Groopman JE (2001) Stimulation of β1 integrin induces tyrosine phosphorylation of VEGF receptor-3 and modulates cell migration. J Biol Chem 276:41950-41957
46. Ayadi A, Suelves M, Dolle P, Wasylyk B (2001) Net, an Ets ternary complex transcription factor, is expressed in sites of vasculogenesis, angiogenesis, and chondrogenesis during mouse development. Mech Dev 102:205-208
47. Ayadi A, Zheng H, Sobieszczuk P, Buchwalter G, Moerman P, Alitalo K, Wasylyk B (2001) Net-targeted mutant mice develop a vascular phenotype and up-regulate egr-1. EMBO J 20:5139-5152
48. Nibbs RJB et al. (2001) The β-chemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors. Am J Pathol 158:867-877
49. Hub E, Rot A (1988) Binding of RANTES, MCP-1, MCP-3, and MIP-1 alpha to cells in human skin. Am J Pathol 152:749-757
50. Kolodkin AL, Levengood DV, Rowe EG, Tai YT, Giger RJ, Ginty DD (1997) Neuropilin is a semaphorin III receptor. Cell 90:753-762
51. He Z, Tessier-Lavigne M (1997) Neuropilin is a receptor for the axonal chemorepellent semaphorin III. Cell 90:739-751
52. Chen H, Chedotal A, He Z, Goodman CS, Tessier-Lavigne M (1997) Neuropilin-2, a novel member of the neuropilin family, is a high affinity receptor for the semaphorins sema E and sema IV but not sema III. Neuron 19:547-559
53. Soker S, Takashima S, Miao HQ, Neufeld G, Klagsbrun M (1998) Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92:735-745
54. Migdal M, Huppertz B, Tessler S, Comforti A, Shibuya M, Reich R, Baumann H, Naufeld G (1998) Neuropilin-1 is a placenta growth factor-2 receptor. J Biol Chem 273:22272-22278
55. Mäkinen T, Olofsson B, Karpanen T, Hellman U, Soker S, Klagsbrun M, Eriksson U, Alitalo K (1999) Differential binding of vascular endothelial growth factor B splice and proteolytic isoforms to neuropilin-1. J Biol Chem 274:21217-21222
56. Gluzman-Poltorak Z, Cohen T, Herzog Y, Neufeld G (2000) Neuropilin-2 and neuropilin-1 are receptors for the 165-amino acid form of vascular endothelial growth factor (VEGF) and of placenta growth factor-2, but not neuropilin-2 functions as a receptor for the 145-amino acid form of VEGF. J Biol Chem 275:18040-18045
57. Gagnon ML, Bielenberg DR, Gechtman Z, Miao HQ, Takashima S, Soker S, Klagsbrun M (2000) Identification of a natural soluble neuropilin-1 that binds vascular endothelial growth factor: In vivo expression and antitumor activity. Proc Natl Acad Sci USA 97:2573-2578
58. Kawasaki T, Kitsukawa T, Bekku Y, Matsuda Y, Sanbo M, Yagi T, Fujisawa H (1999) A requirement for neuropilin-1 in embryonic vessel formation. Development 126:4895-4902
59. Kitsukawa T, Shimono A, Kawakami A, Kondoh H, Fujisawa H (1995) Overexpression of a membrane protein, neuropilin, in chimeric mice causes anomalies in the cardiovascular system, nervous system and limbs. Development 121:4309-4318
60. Giger RJ et al. (2000) Neuropilin-2 is required in vivo for selective axon guidance responses to secreted semaphorins. Neuron 25:29-41
61. Chen H, Bagri A, Zupicich JA, Zou Y, Stoeckli E, Pleasure SJ, Lowenstein DH, Skarnes WC, Chedotal A, Tessier-Lavigne M (2000) Neuropilin-2 regulates the development of selective cranial and sensory nerves and hippocampal mossy fiber projections. Neuron 25:43-56
62. Takahashi T, Fournier A, Nakamura F, Wang LH, Murakami Y, Kalb RG, Fujisawa H, Strittmatter SM (1999) Plexin-neuropilin-1 complexes form functional semaphorin-3A receptors. Cell 99:59-69
63. Tamagnone L et al. (1999) Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates. Cell 99:71-80
64. Karkkainen MJ et al. (2001) A model for gene therapy of human hereditary lymphedema. Proc Natl Acad Sci USA 98:12677-12682
65. Jones N, Iljin K, Dumont DJ, Alitalo K (2001) Tie receptors: New modulators of angiogenic and lymphangiogenic responses. Nat Rev Mol Cell Biol 2:257-267
66. Maisonpierre PC et al. (1997) Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277:55-60
67. Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato TN, Yancopoulos GD (1996) Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87:1161-1169
68. Gale NW et al. Angiopoietin-2 is Required for Postnatal Angiogenic Remodeling, as Well as for Lymphatic Patterning and Function. (submitted)
69. Rockson SG (2001) Lymphedema. Am J Med 110:288-295
70. Witte MH, Way DL, Witte CL, Bernas M (1997) Lymphangiogenesis: Mechanisms, significance and clinical implications, in Regulation of Angiogenesis (Goldberg ID, Rosen EM, eds) pp. 65-112. Birkhäuser Verlag, Basel
71. Bollinger A, Isenring G, Franzeck UK, Brunner U (1983) Aplasia of superficial lymphatic capillaries in hereditary and connatal lymphedema (Milroy's disease). Lymphology 16:27-30
72. Pfister G, Saesseli B, Hoffmann U, Geiger M, Bollinger A (1990) Diameters of lymphatic capillaries in patients with different forms of primary lymphedema. Lymphology 23:140-144
73. Bollinger A (1993) Microlymphatics of human skin. Int J Microcirc Clin Exp 12:1-15
74. Ferrell RE, Levinson KL, Esman JH, Kimak MA, Lawrence EC, Barmada MM, Finegold DN (1998) Hereditary lymphedema: Evidence for linkage and genetic heterogeneity. Hum Mol Genet 7:2073-2078
75. Witte MH, Erickson R, Bernas M, Andrade M, Reiser F, Conlon W, Hoyme HE, Witte CL (1998) Phenotypic and genotypic heterogeneity in familial Milroy lymphedema. Lymphology 31:145-155
76. Evans AL, Brice G, Sotirova V, Mortimer P, Beninson J, Burnand K, Rosbotham J, Child A, Sarfarazi M (1999) Mapping of primary congenital lymphedema to the 5q35.3 region. Am J Hum Genet 64:547-555
77. Aprelikova O, Pajusola K, Partanen J, Armstrong E, Alitalo R, Bailey SK, McMahon J, Wasmuth J, Huebner K, Alitalo K (1992) FLT4, a novel class III receptor tyrosine kinase in chromosome 5q33-qter. Cancer Res 52:746-748
78. Karkkainen MJ, Ferrell RE, Lawrence EC, Kimak MA, Levinson KL, McTigue MA, Alitalo K, Finegold DN (2000) Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema. Nat Genet 25:153-159
79. Irrthum A, Karkkainen MJ, Devriendt K, Alitalo K, Vikkula M (2000) Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase. Am J Hum Genet 67:295-301
80. Corbett CRR, Dale RF, Coltart DJ, Kinmonth JB (1982) Congenital heart disease in patients with primary lymphoedemas. Lymphology 15:85-90
81. Mangion J et al. (1999) A gene for lymphedema-distichiasis maps to 16q24.3. Am J Hum Genet 65:427-432
82. Bell R et al. (2000) Reduction of the genetic interval for lymphoedema-distichiasis to below 2 Mb. J Med Genet 37:725-726
83. Fang J, Dagenais SL, Erickson RP, Arlt MF, Glynn MW, Gorski JL, Seaver LH, Glover TW (2000) Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome. Am J Hum Genet 67:1382-1388
84. Miura N, Wanaka A, Tohyama M, Tanaka K (1993) MFH-1, a new member of the fork head domain family, is expressed in developing mesenchyme. FEBS Lett 326:171-176
85. Iida K et al. (1997) Essential roles of the winged helix transcription factor MFH-1 in aortic arch patterning and skeletogenesis. Development 124:4627-4638
86. Winnier GE, Hargett L, Hogan BL (1997) The winged helix transcription factor MFH1 is required for proliferation and patterning of paraxial mesoderm in the mouse embryo. Genes Dev 11:926-940
87. Smith RS, Zabaleta A, Kume T, Savinova OV, Kidson SH, Martin JE, Nishimura DY, Alward WL, Hogan BL, John SW (2000) Haploinsufficiency of the transcription factors FOXC1 and FOXC2 results in aberrant ocular development. Hum Mol Genet 9:1021-1032
88. Bell R et al. (2001) Analysis of lymphoedema-distichiasis families for FOXC2 mutations reveals small insertions and deletions throughout the gene. Hum Genet 108:546-551
89. Finegold DN, Kimak MA, Lawrence EC, Levinson KL, Cherniske EM, Pober BR, Dunlap JW, Ferrell RE (2001) Truncating mutations in FOXC2 cause multiple lymphedema syndromes. Hum Mol Genet 10:1185-1189
90. Bull LN, Roche E, Song EJ, Pedersen J, Knisely AS, van der Hagen CB, Eiklid K, Aagenaes Ø, Freimer NB (2000) Mapping of the locus for cholestasis-lymphedema syndrome (Aagenaes syndrome) to a 6.6-cM interval on chromosome 15q. Am J Hum Genet 67:994-999
91. Zinn AR et al. (1998) Evidence for a Turner syndrome locus or loci at Xp11.2-p22.1. Am J Hum Genet 63:1757-1766
92. Yonemura Y et al. (1999) Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer. Clin Cancer Res 5:1823-1829
93. Achen MG, Williams RA, Minekus MP, Thornton GE, Stenvers K, Rogers PA, Lederman F, Roufail S, Stacker SA (2001) Localization of vascular endothelial growth factor-D in malignant melanoma suggests a role in tumor angiogenesis. J Pathol 193:147-154
94. Valtola R, Salven P, Heikkila P, Taipale J, Joensuu H, Rehn M, Pihlajaniemi T, Weich H, deWaal R, Alitalo K (1999) VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer. Am J Pathol 154:1381-1390
95. Karpanen T, Egeblad M, Karkkainen MJ, Kubo H, Jackson DG, Ylä-Herttuala S, Jäättelä M, Alitalo K (2001) Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Res 61:1786-1790
96. Skobe M, Hawighorst T, Jackson DG, Prevo R, Janes L, Velasco P, Riccardi L, Alitalo K, Claffey K, Detmar M (2001) Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 7:192-198
97. Skobe M, Hamberg LM, Hawighorst T, Schirner M, Wolf GL, Alitalo K, Detmar M (2001) Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma. Am J Pathol 159:893-903
98. Kadambi A, Carreira CM, Yun C, Padera TP, Dolmans D, Carmeliet P, Fukumura D, Jain RK (2001) Vascular endothelial growth factor (VEGF)-C differentially affects tumor vascular function and leukocyte recruitment: Role of VEGF-receptor 2 and host VEGF-A. Cancer Res 61:2404-2408
99. Stacker SA, Caesar C, Baldwin ME, Thornton GE, Williams RA, Prevo R, Jackson DG, Nishikawa S, Kubo H, Achen MG (2001) VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med 7:186-191
100. Veikkola T, Karkkainen MJ, Claesson-Welsh L, Alitalo K (2000) Regulation of angiogenesis via vascular endothelial growth factor receptors. Cancer Res 60:203-212